TipRanks on MSN
GSK subsidiary initiates litigation against AnaptysBio
GSK (GSK) subsidiary Tesaro confirms it has initiated litigation against AnaptysBio (ANAB) in the Delaware Chancery Court. This action contends ...
Investor's Business Daily on MSN
Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.
Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more ...
Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced that ProFound Therapeutics and Quotient Therapeutics have entered into separate ...
GSK has picked a novel protein biotech and a genomics biotech as its first collaborators under a $7 billion biobucks deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback